Powering the pharmacovigilance engine: why AI’s role is pivotal now
John Cogan, COO, Qinecsa outlines the opportunity presented by AI-driven automation to transform pharmacovigilance, both to address soaring workloads and costs, and to inject new strategic purpose into the function’s role. Pharmacovigilance (PV), and most notably its core task of tracking and processing adverse events (AEs), is both essential for regulatory compliance and a huge and
READ MORE